Skip to main content
. 2016 Jun 13;7(32):51598–51607. doi: 10.18632/oncotarget.9956

Table 1. Baseline characteristics of the two propensity-matched groups stratified by HKLC criteria.

Within HKLC criteria Outside HKLC criteria
Surgery TACE P Surgery TACE P
(n = 237) (n = 237) (n = 117) (n = 117)
Age, years 0.403 0.226
 ≤ 60 171 (72.2) 179 (75.5) 84 (71.8) 92 (78.6)
 > 60 66 (27.8) 58 (24.5) 33 (28.2) 25 (21.4)
Sex 0.882 0.306
 Female 26 (11.0) 25 (10.5) 11 (9.4) 16 (13.7)
 Male 211 (89.0) 212 (89.5) 106 (90.6) 101 (86.3)
Total bilirubin, μmol/L 0.831 0.851
 ≤ 20.4 178 (75.1) 180 (75.9) 100 (85.5) 101 (86.3)
 > 20.4 59 (24.9) 57 (24.1) 17 (14.5) 16 (13.7)
Serum ALT, u/L 0.456 0.353
 ≤ 42 175 (73.8) 182 (76.8) 72 (61.5) 65 (55.6)
 > 42 62 (26.2) 55 (23.2) 45 (38.5) 52 (44.4)
Serum GGT, u/L 0.565 0.420
 ≤ 54 87 (36.7) 81 (34.2) 48 (41.0) 42 (35.9)
 > 54 150 (63.3) 156 (65.8) 69 (59.0) 75 (64.1)
Serum AFP, ng/mL 0.412 0.307
 ≤ 20 62 (26.2) 70 (29.5) 24 (20.5) 18 (15.4)
 > 20 175 (73.8) 167 (70.5) 93 (79.5) 99 (84.6)
Tumor size, cm 1.000 1.000
 ≤ 5 149 (62.9) 149 (62.9) 9 (7.7) 9 (7.7)
 > 5 88 (37.1) 88 (37.1) 108 (92.3) 108 (92.3)
Tumor number 1.000 0.592
 ≤ 3 212 (89.5) 212 (89.5) 48 (41.00%) 44 (37.60%)
 > 3 25 (10.5) 25 (10.5) 69 (59.00%) 73 (62.40%)
Tumor thrombus 1.000 0.346
 Without 217 (91.6) 217 (91.6) 41 (35.00%) 48 (41.00%)
 With 20 (8.4) 20 (8.4) 76 (65.00%) 69 (59.00%)
Tumor location 0.266 0.540
 One lobe 140 (59.1) 128 (54.0) 26 (22.2) 30 (25.6)
 More than one lobe 97 (40.9) 109 (46.0) 91 (77.8 87 (74.4)

Abbreviations: TACE, transcatheter arterial chemoembolization; ALT: alanine aminotransferase; GGT, gamma-glutamyl transferase; AFP, alpha-fetoprotein.